Open-label Study of TH-302 and Dexamethasone With or Without Bortezomib or Pomalidomide in Subjects With Relapsed/Refractory Multiple Myeloma
Clinical trial NCT01522872 · UNKNOWN
Trial details
- NCT number
- NCT01522872
- Sponsor
- Threshold Pharmaceuticals
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-02-01
- Primary completion
- 2016-09-01
- Enrollment
- 98
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.